Showing results (31-40 of 360) with videos related to
Sort By:
Pageof 36
European Journal of Pediatrics|December 29, 2011
Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populationsB Paes, I Mitchell, A Li, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 2, 2012
A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)B Paes, I Mitchell, A Li, et al.Multiple Sclerosis and Related Disorders|April 17, 2015
Computerized cognitive testing for patients with multiple sclerosisHelen Lapshin, Paul O'Connor, Krista L Lanctôt, et al.The Journal of Clinical Psychiatry|February 13, 2019
Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-AnalysisMyuri Ruthirakuhan, Krista L Lanctôt, Danielle Vieira, et al.Journal of Medical Economics|November 20, 2010
Changing costs and the impact on RSV prophylaxisKelly A Smart, Bosco A Paes, Krista L LanctôtAddiction (Abingdon, England)|January 1, 1995
Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problemsC A Naranjo, K E Bremner, K L LanctôtJournal of Medical Economics|July 27, 2010
The cost effectiveness of palivizumab: a systematic review of the evidenceKelly A Smart, Krista L Lanctôt, Bosco A PaesCNS Drugs|October 12, 2010
The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's diseaseJaclyn Cappell, Nathan Herrmann, Stephen Cornish, et al.International Psychogeriatrics|July 28, 2006
Behavioral correlates of GABAergic disruption in Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann, Lana Rothenburg, et al.Journal of Neurology|June 6, 2013
Sub-threshold cognitive impairment in multiple sclerosis: the association with cognitive reserveAnthony Feinstein, Helen Lapshin, Paul O'Connor, et al.Pageof 36